Bio-Techne President Steven C. Crouse Exercises RSUs, Surrenders 1,947 Shares

What Happened

• Steven C. Crouse, President — Diagnostics & Spatial Biology at Bio-Techne (TECH), had 5,423 restricted stock units (RSUs) vest and convert into 5,423 shares on 2026-08-15. To satisfy tax withholding, 1,947 of those shares were surrendered at $72.40 per share, totaling $140,963. After withholding, the net shares delivered to Crouse were 3,476 shares.
• Transaction codes: M = exercise/conversion of derivative (RSU vesting/conversion); F = payment of tax liability via share surrender (withholding). The reported per-share value for withholding was $72.40.

Key Details

• Transaction date: 2026-08-15; Form 4 filed: 2026-08-18 (filed three calendar days after the transaction date — Form 4s are normally due within two business days, so this may be late by one business day).
• Shares converted (vested) on 8/15/2026: 1,379 (F4), 1,868 (F5) and 2,176 (F6) — total 5,423 RSUs converted to common shares.
• Tax withholding: 1,947 shares surrendered at $72.40/share = $140,963 (code F).
• Net shares received by insider: 5,423 − 1,947 = 3,476 shares.
• Footnote F1: each RSU equals the contingent right to one share of Bio‑Techne common stock.
• No open-market sale or purchase reported — this was vesting/conversion and tax-withholding, not a discretionary sell/buy.

Context

• This was a standard RSU vest-and-settle event (derivative conversion plus share surrender to cover taxes). That is a routine, non-dispositive corporate compensation event and does not necessarily signal a change in insider sentiment.
• Because the withholding was done via share surrender (not cash), this is sometimes called a net settlement for taxes rather than a market sale.